{{Rsnum
|rsid=10774625
|Gene=ATXN2
|Chromosome=12
|position=111472415
|Orientation=plus
|GMAF=0.225
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ATXN2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 23.0 | 45.1 | 31.9
| HCB | 0.0 | 0.7 | 99.3
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 1.8 | 17.5 | 80.7
| CHB | 0.0 | 0.7 | 99.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 2.0 | 20.0 | 78.0
| LWK | 0.0 | 0.9 | 99.1
| MEX | 3.4 | 39.7 | 56.9
| MKK | 0.0 | 0.0 | 0.0
| TSI | 26.7 | 55.4 | 17.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21060863
|Trait=None
|Title=Four novel Loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivo
|RiskAllele=A
|Pval=2E-13
|OR=1.5000
|ORtxt=[1.11-1.89] um increase
|OA=1
}}

{{PMID Auto
|PMID=23844121
|Title=Thrombotic Antiphospholipid Syndrome Shows Strong Haplotypic Association with SH2B3-ATXN2 Locus
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}